# Selenium Intervention Registry Randomized Trial in Heart Failure

Study · id `cardio:ct-nct07543562` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07543562](<https://clinicaltrials.gov/study/NCT07543562>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07543562

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 4326 participants.

## Technical summary

Registry record NCT07543562. Randomized; triple masking; primary purpose treatment. Start 2026-04-01 (actual); primary completion 2030-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 4326 participants (planned count; ClinicalTrials.gov record NCT07543562, source copy `cardio:ctgov-nct07543562-2026-04-22`, retrieved 2026-10-26)
- Started: 2026-04-01 (actual) (ClinicalTrials.gov record NCT07543562, source copy `cardio:ctgov-nct07543562-2026-04-22`, retrieved 2026-10-26)
- Primary completion: 2030-03 (anticipated) (ClinicalTrials.gov record NCT07543562, source copy `cardio:ctgov-nct07543562-2026-04-22`, retrieved 2026-10-26)
- Completion: 2031-03 (anticipated) (ClinicalTrials.gov record NCT07543562, source copy `cardio:ctgov-nct07543562-2026-04-22`, retrieved 2026-10-26)
- Countries: Norway; Sweden (ClinicalTrials.gov record NCT07543562, source copy `cardio:ctgov-nct07543562-2026-04-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07543562-2026-04-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Selenium Intervention Registry Randomized Trial in Heart Failure
- Acronym: SIRI-HF
- Condition: Heart Failure
- Condition: Heart Failure and Reduced Ejection Fraction
- Condition: Heart Failure and Mildly Reduced Ejection Fraction
- Condition: Heart Failure and Preserved Ejection Fraction
- Condition: Selenium Supplementation
- Condition: Selenium
- Condition: Cognitive Functioning
- Intervention (Dietary supplement): Selenium Supplement
- Intervention (Dietary supplement): Placebo
- Lead sponsor: Skane University Hospital
- Lead sponsor class: OTHER
- Collaborator: Uppsala University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart failure with mildly reduced or preserved ejection fraction (`cardio:hfpef`)
- Registry condition terms include this condition: Heart failure with reduced ejection fraction (HFrEF) (`cardio:hfref`)
- Registry lists this organization as the lead sponsor: Skane University Hospital (`cardio:org-skane-university-hospital`)
- Registry lists this organization as a collaborator: Uppsala University (`cardio:org-uppsala-university`)

## Provenance

Content hash: be1b5747aeadc3e40c2febc7ec4de9f19ba29f218796848b37838e1af5ee4528
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
